Características clínicas y bioquímicas de cirrosis hepática compensada. Hospital Universitario de Caracas, julio-septiembre 2019
Resumen
Palabras clave
Texto completo:
PDFReferencias
Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1736–88.
WHO. The top 10 causes of death. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-266. doi: 10.1016/S2468-1253(19)30349-8.
Jepsen P, Younossi ZM. The global burden of cirrhosis: A review of disability-adjusted life-years lost and unmet needs. J Hepatol. 2021 Jul;75 Suppl 1:S3-S13. doi: 10.1016/j.jhep.2020.11.042. PMID: 34039490
Escorcia Charris E, Marrugo Balceiro W., Balceiro W. Caracterización epidemiológica y clínica de la cirrhosis hepatica en un centro regional del caribe colombiano: clínica general del norte. Enero 2012 a marzo 2017. Bioc. 2018. 13(1):17-30.
Venezuela: liver disease. https://www.worldlifeexpectancy.com/venezuela-liver-disease.
Czaja AJ. Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis. Aliment Pharmacol Ther 2014; 39: 385–406.
Sohrabpour AA, Mohamadnejad M, Malekzadeh R. Review article: the reversibility of cirrhosis. Aliment Pharmacol Ther 2012; 36: 824–32.
Ge PS, Runyon BA. Treatment of patients with cirrhosis. N Engl J Med 2016; 375: 767–77.
Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838–51.
Martínez D, Papuzinski C, Stojanova J, Arancibia M. General concepts in biostatistics and clinical epidemiology: observational studies with case-control design. Medwave. 2019 Nov 7;19(10): e7716.
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-4.
de Franchis R, Baveno VF. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53:762-768
Tsoris A, Marlar CA. Use Of The Child Pugh Score In Liver Disease. 2020 May 17. In: Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2020 Jan–. PMID: 31194448
Kamath PS, Kim WR; Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology. 2007 Mar;45(3):797-805.
Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003 Aug;38(2):518-26. doi: 10.1053/jhep.2003.50346.
Francoz C, Nadim MK, Baron A, Prié D, et al.Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations. Hepatology. 2014 Apr;59(4):1514-21
Lebroc D, Reina A, Camacho J, Massip M. Caracterización Clínica de los Pacientes con Cirrosis Hepática en el Hospital Provincial Docente “Doctor Antonio Luaces Iraola”. MediCiego 2011, 17(2):
Campollo O, Valencia J, Berumen A, Perez M, Pandero A, Segura J. Características epidemiológicas de la cirrosis hepática en el Hospital Civil de Guadalajara. Salud pública de México.1997;39(3):195-200
Bustios C, Davalos M, Roman R, Zumaeta E. Características Epidemiológicas y Clínicas de la Cirrosis Hepática en la Unidad de Hígado del HNERM Es-Salud. Rev. gastroenterol. 2007;27(3):238-245
Cortes-Mancera F, Loureiro CL, Hoyos S, et al. Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia. Hepatitis Research and Treatment. 2011; 2011:363205.
Medina E. Y Kaempffer A. Cirrosis hepática en Chile. Revista Chilena de Salud Pública 2002; Vol 6. (1): 3.
Allison RD, Tong X, Moorman AC, et al. Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010. J Hepatol. 2015;63: 822–828.
van der Meer AJ, Wedemeyer H, Feld JJ, et al. Life expectancy in patients with chronic HCV infection and cirrhosis compared with a general population. JAMA. 2014; 312:1927–1928.
Baig W, Nagaraja M, Varma M, R Prabhu. Platelet count to spleen diameter ratio for the diagnosis of esophageal varices: Is it feasible? Can J Gastroenterol 2008;22(10):825- 828.
Rehm J, Taylor B, Mohapatra S, et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev 2010; 29:437-445.
World Health Organization. In: Poznyak V, Rekve D, eds. Global Status Report on Alcohol and Health 2018. Geneva: WHO; 2018.
Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ. 2018;362: k2817.
Grant BF, Chou SP, Saha TD, et al. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry. 2017;74(9):911-923.
Sort P, Muelas M, Isava A, Llaó Y. Porta Fetal.Diagnostic Accuracy of Abdominal Ultrasound in the Screening of Esophageal Varices in Patients With Cirrhosis. Eur J Gastroenterol Hepatology 2014;26(12):1335-1341.
Berzigotti A, Gilbert R, Abraldes J, Nicolau C, Bru C et al. Spleen enlargement on follow-up evaluation: a noninvasive predictor of complications of portal hypertension in cirrhosis, Clin Gastroenterol Hepatology 2008; 6 (10):1129-34.
Akande K, Akere A, Otegbayo JA, Ola SO. Precision of non-endoscopic predictors of esophageal varices in liver cirrhosis using platelet count, spleen size, and portal vein diameter Afr J Med Med Sci 2016; 45 (3):2
DOI: http://dx.doi.org/10.61155/gen.v75i4.580
VIDEOS GEN
Autor: Dr. Freddy Pereira Graterol
CPRE. Sitio de sección del ducto pancreático principal | Drenaje transgástrico de pseudoquiste pancreático | CPRE. Sección del ducto hepático izquierdo por traumatismo de abdomen |
Autora: Dra. Anais Karina García Yaraure
Cavernomatosis portal Pre Colocacion de TIPS. | Cavernomatosis portal Post Colocacion de TIPS. |
Revista GEN
ISSN: 0016-3503 e-ISSN: 2477-975X